A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 4, 2006, Pages

  Kaneko, Kazuhiro ^a   Yonemitsu, Yoshikazu ^a   Fujii, Takaaki ^a   Onimaru, Mitsuho ^a   Jin, Chen Hao ^a   Inoue, Makoto ^b   Hasegawa, Mamoru ^b   Onohara, Toshihiro ^a   Maehara, Yoshihiko ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b University of Tokyo   (Japan)

Author keywords

Critical limb ischemia; Fibroblast growth factor 2; Free radicals; Neutrophils

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2; NORPHENAZONE; SCAVENGER; DRUG DERIVATIVE; PHENAZONE; PHENYLMETHYLPYRAZOLONE;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GENE TRANSFER; HINDLIMB; MALE; METABOLIC SYNDROME X; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; SENDAI VIRUS; ANIMAL; GENETICS; HOSPITALIZATION; NEPHROSIS; REPERFUSION INJURY; RHABDOMYOLYSIS; TREATMENT OUTCOME; VASCULARIZATION; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIPYRINE; FIBROBLAST GROWTH FACTOR 2; FREE RADICAL SCAVENGERS; GENE TRANSFER TECHNIQUES; HINDLIMB; MALE; METABOLIC SYNDROME X; NEPHROSIS; RATS; RATS, WISTAR; REPERFUSION INJURY; RHABDOMYOLYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33646102687     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01006.2005     Document Type: Article

References (38)

1. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, Sarau HM, Clark RK, and Griswold DE. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 29: 336-345, 1991.
2. Blaisdell FW, Steele M, and Allen RE. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 84: 822-834, 1978.
3. Chatelain P, Latour JG, Tran D, de Lorgeril M, Dupras G, and Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation 75: 1083-1090, 1987.
4. Collinson DJ and Donnelly R. Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg 28: 9-23, 2004.
5. Epstein SE, Fuchs S, Zhou YF, Baffour R, and Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 49: 532-542, 2001.
6. Gujral JS, Liu J, Farhood A, Hinson JA, and Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 286: G499-G507, 2004.
7. Haimovici H. Muscular, renal, and metabolic complications of acute arterial occlusions: myonephropathic-metabolic syndrome. Surgery 85: 461-468, 1979.
8. Hetzel J, Balletshofer B, Rittig K, Walcher D, Kratzer W, Hombach V, Haring HU, Koenig W, and Marx N. Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol 25: 1804-1809, 2005.
9. Hove CV, Carreer-Bruhwyler F, G'eczy J, and Herman AG. Long-term treatment with the NO-donor molsidomine reduces circulating ICAM-1 levels in patients with stable angina. Atherosclerosis 180: 399-405, 2005.
10. Ito K, Ozasa H, and Horikawa S. Edaravone protects against lung injury induced by intestinal ischemia/reperfusion in rat. Free Radic Biol Med 38: 369-374, 2005.
11. Ito U, Ohno K, Suganuma Y, Suzuki K, and Inaba Y. Effect of steroid on ischemic brain edema. Analysis of cytotoxic and vasogenic edema occurring during ischemia and after restoration of blood flow. Stroke 11: 166-172, 1980.
12. Jiang ZS, Padua RR, Ju H, Doble BW, Jin Y, Hao J, Cattini PA, Dixon IM, and Kardami E. Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C. Am J Physiol Heart Circ Physiol 282: H1071-H1080, 2002.
13. Jiang ZS, Srisakuldee W, Soulet F, Bouche G, and Kardami E. Nonangiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res 62: 154-166, 2004.
14. Korthuis RJ, Granger DN, Townsley MI, and Taylor AE. The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 57: 599-609, 1985.
15. Kusterer K, Bojunga J, Enghofer M, Heidenthal E, Usadel KH, Kolb H, and Martin S. Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice. Am J Physiol Gastrointest Liver Physiol 275: G377-G380, 1998.
16. Labarrere C, Nelson DR, Miller SJ, Nieto JM, Conner JA, Pitts DE, Kirlin PC, and Halbrook HG. Value of Serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure. Circulation 102: 1549-1555, 2000.
17. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, and Annex BH (TRAFFIC Investigators). Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359: 2053-2058, 2002.
18. Lefaucheur JP, Gjata B, Lafont H, and Sebille A. Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-β1. J Neuroimmunol 70: 37-44, 1996.
19. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Komori K, Fukumura M, Hou X, Hasegawa M, Sugimachi K, and Sueishi K. Gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of VEGF165, but not of FGF-2. Circ Res 90: 966-973, 2002.
20. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, and Sueishi K. Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in atherosclerotic intima of human coronary arteries. Hum Pathol 36: 330-340, 2005.
21. Onimaru M, Yonemitsu Y, Nakagawa K, Masaki I, Tanii M, Okano S, Shirasuna K, Hasegawa M, and Sueishi K. FGF-2 gene transfer can stimulate HGF expression, irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 91: 723-730, 2002.
22. Padua RR, Sethi R, Dhalla NS, and Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem 143: 129-135, 1995.
23. Rajagopalan S, Mohler ER III, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, and Annex BH. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108: 1933-1938, 2003.
24. Sheikh F, Sontag DP, Fandrich RR, Kardami E, and Cattini PA. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. Am J Physiol Heart Circ Physiol 280: H1039-H1050, 2001.
25. Shoji T, Yonemitsu Y, Komori K, Tanii M, Itoh H, Sata S, Shimokawa H, Hasegawa M, Sueishi K, and Maehara Y. Intramuscular gene transfer of FGF-2 attenuates regenerative endothelial dysfunction and inhibits neointimal hyperplasia of autologous femoral vein grafts in poor runoff limbs of rabbit. Am J Physiol Heart Circ Physiol 285: H173-H182, 2003.
26. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ, Moon T, and Chronos NA. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105: 788-793, 2002.
27. Sugiyama Y, Yanagisawa K, Tominaga SI, and Kitamura S. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages. Eur Respir J 14: 1113-1116, 1999.
28. Spark JI, Scott DJ, Chetter IC, Guillou PJ, and Kester RC. Does soluble intercellular adhesion molecule-1 (ICAM-1) affect neutrophil activation and adhesion following ischaemia-reperfusion? Eur J Vasc Endovasc Surg 17: 115-120, 1999.
29. Suzuki F, Hashikura Y, Ise H, Ishida A, Nakayama J, Takahashi M, Miyagawa S, and Ikeda U. MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats. Transpl Int 18: 844-853, 2005.
30. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, and Isner JM. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 93: 662-670, 1994.
31. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, and Isner JM. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94: 3281-3290, 1996.
32. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Hasegawa M, Maehara Y, Hashizume M, and Sueishi K. Essential role of PDGFRα/p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo. Role of PDGFRα during angiogenesis. Circ Res 94: 1186-1194, 2004.
33. Watanabe K, Kinoshita S, and Nakagawa H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun 161: 1093-1099, 1989.
34. Watanabe K, Koizumi F, Kurashige Y, Tsurufuji S, and Nakagawa H. Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Exp Mol Pathol 55: 30-37, 1991.
35. Watanabe T, Morita I, Nishi H, and Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 33: 81-87, 1988.
36. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, and Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401-1403, 1992.
37. Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Dian J, Steel R, Phillipe S, Zhu J, Jeffery PK, Kato A, Hasan MK, Masaki I, Nagai Y, Fukumura M, Hasegawa M, Geddes DM, and Alton EWFW. Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol 18: 970-973, 2000.
38. Zhang ZG and Chopp M. Measurement of myeloperoxidase immunoreactive cells in ischemic brain after transient middle cerebral artery occlusion in the rat. Neurosci Res Commun 20: 85-91, 1997.